188 P. BLANCKAERT ET AL.
1-octanol)/(counts/g in PBS). All the experimental
measurements were performed in triplicate.
5. Mintun MA, Sheline YI, Moerlein SM, Vlassenko
AG, Huang Y, Snyder AZ. Biol Psychiatry 2004; 55:
217–224.
Biodistribution in NMRI mice
6. Peremans K, Audenaert K, Coopman F, Hoybergs Y,
Slegers G, Van Bree H, Verschooten F, Dierckx R.
Vlaams Diergeneesk Tijdschr 2002; 71: 340–347.
7. Peremans K, Audenaert K, Coopman F, Blanckaert
P, Jacobs F, Otte A, Verschooten F, Van Bree H, van
Heeringen K, Mertens J, Slegers G, Dierckx R. Eur J
Nucl Med Mol Imaging 2003; 30: 1538–1546.
8. Peremans K, Audenaert K, Hoybergs Y, Otte A,
Goethals I, Gielen I, Blankaert P, Vervaet M, Van
Heeringen C, Dierckx R. Eur J Nucl Med Mol
Imaging 2005; 32: 708–716.
A biodistribution study of [123I]-3-I-CO was performed
in NMRI mice. Adult male NMRI mice (weight 20–25 g)
were injected in the tail vein with 20–50 mCi of [123I]-3-I-
CO. At various time points post injection (20, 40 s, 1, 2,
5, 10, 30, 60, 120 min, n ¼ 3 per time point) the mice
were sacrificed. Blood was collected and the animals
were rapidly dissected. Blood samples and organs of
interest were weighed and counted for radioactivity in
an automated gamma counter. The results were decay
corrected and tissue radioactivity concentrations were
expressed as a percentage of the injected dose per gram
of tissue (% ID/g, mean ꢀ standard deviation).
9. Sheline YI, Mintun MA, Moerlein SM, Vlassenko AG,
Xue F, Snyder AZ. Biol Psychiatry 2003; 53: 10S.
10. Marner L, Knudsen GM, Madsen K, Haugbol S,
Vogel A, Holm S, Baare W, Hasselbalch SG. Neuro-
image 2006; 31: T101.
Conclusion
11. Ngan ETC, Yatham LN, Ruth TJ, Liddle PF. Am J
Psychiatry 2000; 157: 1016–1018.
This work reports the synthesis, radiolabelling and
in vivo evaluation in NMRI mice of [123I]-(4-fluorophe-
12. Halldin C, Lundkvist C, Ginovart N, Nyberg S, Hall
H, Swahn CG, Carr AA, Brunner F, Farde L. J Nucl
Med 1996; 37: 424.
nyl)[1-(3-iodophenethyl)piperidin-4-yl]methanone,
a
potential SPECT tracer for visualization of the 5-HT2A
receptor. The tributylstannylprecursor was synthesized
with an overall yield of 15%. The precursor was
radiolabelled with excellent yield (85%). Radiochemical
purity was always >95%. Log P was measured by the
‘shake-flask’ method and was 3.10 ꢀ 0.10. The tracer
showed good uptake in mouse brain (6.3 ꢀ 1.3% ID/g
tissue at 10 min p.i., 2 ꢀ 0.36% ID/g tissue at 1 h p.i.).
These results warrant further research to assess the
potential of [123I]-3-I-CO as a 5-HT2A tracer. More
specifically, regional biodistribution and displacement
studies in larger animals (rats, rabbits) are needed to
demonstrate specific binding in 5-HT2A receptor-rich
brain regions.
13. Kristiansen H, Elfving B, Plenge P, Pinborg LH,
Gillings N, Knudsen GM. Synapse 2005; 58:
249–257.
14. Watabe H, Channing MA, Der MG, Adams HR,
Jagoda E, Herscovitch P, Eckelman WC,
Carson RE. J Cerebral Blood Flow Metab 2000;
20: 899–909.
15. Staley JK, van Dyck CH, Tan PZ, Al Tikriti M,
Ramsby Q, Klump H, Ng C, Garg P, Soufer R,
Baldwin RM, Innis RB. Nucl Med Biol 2001; 28:
271–279.
16. Tan PZ, Baldwin RM, van Dyck CH, Al-Tikriti M,
Roth B, Khan N, Charney DS, Innis RB. Nucl Med
Biol 1999; 26: 601–608.
REFERENCES
17. Catafau AM, Danus M, Bullich S, Llop J, Perich J,
Cunningham VJ, Plaza P, Penengo MM, Eersels
JLH, Squassante L, Ros D, Barbanoj M. J Nucl Med
2006; 47: 919–928.
1. Audenaert K, Van Laere K, Dumont F, Slegers G,
Mertens J, Van Heeringen C, Dierckx RA. Eur J
Nucl Med 2001; 28: 175–182.
2. Audenaert K, Van Laere K, Dumont F, Vervaet M,
Goethals I, Slegers G, Mertens J, van Heerigen C,
Dierckx RA. J Nucl Med 2003; 44: 163–169.
3. Hashimoto T, Kitamura N, Kajimoto Y, Shirai Y,
Shirakawa O, Mita T, Nishino N, Tanaka C.
Psychopharmacology 1993; 112: S35–S39.
18. Catafau AM, Danus M, Bullich S, Nucci G,
Llop J, Abanades S, Cunningham VJ, Eersels
JLH, Pavia J, Farre M. J Nucl Med 2006; 47:
929–937.
19. Fu X, Tan PZ, Kula NS, Baldessarini R, Tamagnan
G, Innis RB, Baldwin RM. J Med Chem 2002; 45:
2319–2324.
4. Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek
B, Brown GM, Wilson AA, Kennedy SH. Am J
Psychiatry 1999; 156: 1029–1034.
20. Wilson AA, Jin L, Garcia A, DaSilva JN, Houle S.
Appl Radiat Isot 2001; 54: 203–208.
Copyright # 2007 John Wiley & Sons, Ltd.
J Label Compd Radiopharm 2007; 50: 183–188
DOI: 10.1002.jlcr